SC 13D - Estrella Immunopharma, Inc. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

4 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

4 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

4 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

Estrella to Begin Trading on NASDAQ Under the Ticker Symbols "ESLA" and "ESLAW" Beginning October 2, 2023NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Estrella Immunopharma, Inc., formerly known as TradeUP Acquisition Corp. ("UPTD") (NASDAQ:UPTD, UPTDW, UPTDU))))), today announced the successful closing of its business combination with Estrella Biopharma, Inc. ("Estrella"), a preclinical-stage biopharmaceutical company developing T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. The resulting combined company will operate under the name Estrella Immunopharma, Inc. and will be led by Estrella Founder and CEO Dr. Cheng Liu. The comb

Gainers TransCode Therapeutics, Inc. (NASDAQ:RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. FaZe Holdings Inc. (NASDAQ:FAZE) gained 46.9% to $0.2247 after falling over 4% on Friday. Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares climbed 23.5% to $0.1472 after gaining 16% on Friday. The company recently announced the sale of its assets relating to AVTX-801 (D-galactose), AVTX-802 (D-mannose) and AVTX-803 (L-fucose) on Sept. 12. Biophytis S.A. (NASDAQ:BPTS) shares gained 22.3% to $1.1250 after the company and Skyepharma announced the signature of a partnership agreement for the production of regulatory ba

Gainers MicroAlgo Inc. (NASDAQ:MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions. Synaptogenix, Inc. (NASDAQ:SNPX) surged 28.7% to $0.3610. Lifezone Metals Limited (NYSE:LZM) gained 27.4% to $15.29. Lifezone Metals recently reported H1 loss of $16.77 per share. SeqLL Inc. (NASDAQ:SQL) gained 26% to $18.04. Heart Test Laboratories, Inc. (NASDAQ:HSCS) climbed 25.2% to $0.4680. Cemtrex, Inc. (NASDAQ:CETX) rose 21.7% to $6.86. Cheche Group Inc. (NASDAQ:CCG) gained 21.1% to $17.99 amid continued volatility following the company's business combination with Prime Impact Acqu

Gainers MSP Recovery, Inc. (NASDAQ:LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. Near Intelligence, Inc. (NASDAQ:NIR) gained 52.5% to $0.3188. Near Intelligence said it is a trusted partner of leading global commercial real estate companies seeking high-quality real estate analytics on any location, building or site. Murphy Canyon Acquisition Corp. (NASDAQ:MURF) shares gained 40.9% to $18.09. Murphy Canyon Acquisition reported stockholder approval of the proposed combination with Conduit Pharmaceuticals. TradeUP Acquisition Corp. (NASDAQ:UPTD) shares climbed 35.8% to $16.63 after surging 26% on Wednesday. The company announced an extension for its initial busin

TradeUP Acquisition Corp (NASDAQ:UPTD) shares are trading higher Thursday. The company has entered into subscription agreements in connection with the closing of its proposed business combination transactions, according to an SEC filing.  What To Know: According to the SEC filing, TradeUP entered into subscription agreements with Lianhe World Limited and Plentiful Limited in connection with the closing of its planned business combination transaction with Estrella Biopharma, Inc.  Lianhe World Limited and Plentiful Limited will each purchase $5,000,000 in shares of the combined company priced at $10 per share.  The filing also stated that the combined company's first day of trading is ant

Gainers Near Intelligence, Inc. (NASDAQ:NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to also serve as the company’s Chief Privacy Officer. Neptune Wellness Solutions Inc. (NASDAQ:NEPT) shares rose 28.5% to $5.03 in pre-market trading after falling 11% on Wednesday. Neptune Wellness announced intention to spinout Sprout Organics pursuant to the Morgan Stanley agreed to transaction. Murphy Canyon Acquisition Corp. (NASDAQ:MURF) shares rose 32.4% to $17.00 in pre-market trading. Murphy Canyon Acquisition reported stockholder approval of the proposed combination with Conduit Pharmace

Estrella to Begin Trading on NASDAQ Under the Ticker Symbols "ESLA" and "ESLAW" Beginning October 2, 2023 NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Estrella Immunopharma, Inc., formerly known as TradeUP Acquisition Corp. ("UPTD") (NASDAQ:UPTD, UPTDW, UPTDU))), today announced the successful closing of its business combination with Estrella Biopharma, Inc. ("Estrella"), a preclinical-stage biopharmaceutical company developing T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.  The resulting combined company will operate under the name Estrella Immunopharma, Inc. and will be led by Estrella Founder and CEO Dr. Cheng Liu. The com

NEW YORK, Sept. 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from September 19, 2023 to October 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $37,432.70 (the "Monthly Extension Fee"), representing $0.05 per Remaining Share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biop

NEW YORK, Aug. 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from August 19, 2023 to September 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $37,432.70 (the "Monthly Extension Fee"), representing $0.05 per Remaining Share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biophar

NEW YORK , July 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from July 19, 2023 to August 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $37,432.70 (the "Monthly Extension Fee"), representing $0.05 per Remaining Share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma,

NEW YORK, July 12, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. ("TradeUP") (NASDAQ:UPTD), a publicly traded special purpose acquisition company, announced that it will hold a special meeting of stockholders of TradeUP on Monday, July 31, 2023 at 9:00 a.m. Eastern Time (the "Special Meeting") to vote on, among others, the proposed business combination (the "Merger") with Estrella Biopharma, Inc. ("Estrella"), a preclinical-stage biopharmaceutical company focusing on cancer therapeutics. On September 30, 2022, the parties entered into a definitive business combination agreement (the "Business Combination Agreement"). On July 11, 2023, the registration statement on Form S-4 (File No. 333-267

NEW YORK, June 20, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from June 19, 2023 to July 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $45,511.00 (the "Monthly Extension Fee"), representing $0.05 per public share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma, Inc.,

NEW YORK, May 19, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from May 19, 2023 to June 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $45,511.00 (the "Monthly Extension Fee"), representing $0.05 per public share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma, Inc., a

NEW YORK, April 13, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from April 19, 2023 to May 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $45,511.00 (the "Monthly Extension Fee"), representing $0.05 per public share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma, Inc.,

NEW YORK, March 17, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from March 19, 2023 to April 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $45,511.00 (the "Monthly Extension Fee"), representing $0.05 per public share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma, Inc

NEW YORK, Feb. 17, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from February 19, 2023 to March 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such Extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $45,511.00 (the "Monthly Extension Fee"), representing $0.05 per public share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biopharma, I